Page 258 - FINAL PROGRAMME 2017
P. 258

P-459 High prevalence of chronic endometritis in women diagnosed with hydrosalpinx during in vitro fertilization treatment
P.E. Bouet1, L. Lapensée2, J. Lefebvre2, G. Legendre1, P. May-Panloup1, H. El Hachem2 1Angers University Hospital, Reproductive Medicine, Angers, France
2Ovo Clinic, Reproductive Medicine, Montreal, Canada
P-461 The reproductive outcome following Atosiban administration around the time of embryo transfer: a systematic review and meta-analysis
L. Craciunas1, M. Kollmann2, N. Tsampras3, N. Raine-Fenning4, M. Choudhary5
1Newcastle University, Newcastle Fertility Centre, Newcastle upon Tyne, United Kingdom
2Medical University of Graz, Department of Obstetrics and Gynecology, Graz, Austria
3Saint Mary's Hospital- Central Manchester University Hospital NHS Trust, Reproductive Medicine, Manchester, United Kingdom
4University of Nottingham, Division of Child Health- Obstetrics and Gynaecology- School of Medicine, Nottingham, United Kingdom
5Newcastle upon Tyne Hospitals NHS Trust, Newcastle Fertility Centre, Newcastle upon Tyne, United Kingdom
P-462 Next generation RNA sequencing on human trophectoderm cells reveals competent blastocysts for single embryo transfer in in vitro fertilisation cycles
P. Ntostis1, G. Kokkali2, J. Huntriss1, E. Kanavakis3, H. Picton1, K. Pantos2, D. Miller1 1LICAMM, Reproduction and Early Development, Leeds, United Kingdom
2Genesis Athens clinic, IVF, Athens, Greece
3University of Athens, Medical Genetics, Athens, Greece
P-463 Interactome between embryo trophectoderm cells and endometrial epithelial and stromal cells: novel insights into implantation process in human
M. Koel1, K. Krjutškov1, A. Reddy2, M. Saare3, S. Katayama2, L. Kumar4, K. Gemzell Danielsson4, F. Lanner5, E. Einarsdottir6, D. Blesa7, C. Simon8, J. Kere2, A. Salumets1, S. Altmäe1
1Competence Centre on Health Technologies, Competence Centre on Health Technologies, Tartu, Estonia 2Karolinska Institutet, Department of Biosciences and Nutrition, Huddinge, Sweden
3Institute of Clinical Medicine- University of Tartu, Department of Obstetrics and Gynecology, Tartu, Estonia
4Karolinska Institutet, Department of Women’s and Children’s Health- Division of Obstetrics and Gynecology, Stockholm, Sweden
5Karolinska Institutet- Karolinska Universitetssjukhuset, Department of Clinical Science- Intervention and Technology and Division of Obstetrics and Gynecology, Stockholm, Sweden
6University of Helsinki, Folkhälsan Institute of Genetics- and Molecular Neurology Research Program, Helsinki, Finland
7Igenomix, Igenomix, Valencia, Spain
8Valencia University/INCLIVA & Igenomix, Valencia University/INCLIVA & Igenomix, Valencia, Spain
258


































































































   256   257   258   259   260